TrialBMC musculoskeletal disorders2017

The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes.

Gabriele De Marco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.